|
NME3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.62929999953421E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.03099999995793E-06 |
| Normal-vs-Stage2 |
3.059700E-02 |
| Normal-vs-Stage3 |
1.013680E-02 |
| Normal-vs-Stage4 |
2.492300E-02 |
| Stage1-vs-Stage2 |
8.990600E-01 |
| Stage1-vs-Stage3 |
4.632000E-01 |
| Stage1-vs-Stage4 |
5.813800E-01 |
| Stage2-vs-Stage3 |
5.734400E-01 |
| Stage2-vs-Stage4 |
6.264800E-01 |
| Stage3-vs-Stage4 |
9.830400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.14319999997304E-06 |
| Normal-vs-AfricanAmerican |
8.629800E-02 |
| Normal-vs-Asian |
5.040700E-03 |
| Caucasian-vs-AfricanAmerican |
7.154800E-01 |
| Caucasian-vs-Asian |
5.336600E-01 |
| AfricanAmerican-vs-Asian |
4.615600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.20069999999906E-05 |
| Normal-vs-Female |
4.23929999999739E-05 |
| Male-vs-Female |
1.595440E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.99560000000121E-05 |
| Normal-vs-Age(41-60Yrs) |
6.08399999999509E-05 |
| Normal-vs-Age(61-80Yrs) |
1.770270E-02 |
| Normal-vs-Age(81-100Yrs) |
4.901000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.689200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.061800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.990000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.733000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.174200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.103000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.993600E-04 |
| Classical-VS-Follicular |
2.144800E-01 |
| Classical-VS-Other |
5.430600E-01 |
| Classical-VS-Normal |
2.29149999997347E-06 |
| Tall-VS-Follicular |
3.951200E-04 |
| Tall-VS-Other |
1.379950E-01 |
| Tall-VS-Normal |
3.788400E-01 |
| Follicular-VS-Other |
9.362400E-01 |
| Follicular-VS-Normal |
1.801860E-04 |
| Other-VS-Normal |
2.019200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.27109999987263E-07 |
| Normal-vs-N1 |
4.806300E-04 |
| N0-vs-N1 |
4.120400E-01 |
|
|
